Innospec Ownership

IOSP Stock  USD 81.72  0.31  0.38%   
Innospec has a total of 24.78 Million outstanding shares. The majority of Innospec outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Innospec to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Innospec. Please pay attention to any change in the institutional holdings of Innospec as this could imply that something significant has changed or is about to change at the company. Also note that almost two hundred twenty-two thousand nine hundred ninety-eight invesors are currently shorting Innospec expressing very little confidence in its future performance.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Innospec. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices.
To learn how to invest in Innospec Stock, please use our How to Invest in Innospec guide.

Innospec Stock Ownership Analysis

About 100.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 1.56. Some equities with similar Price to Book (P/B) outperform the market in the long run. Innospec recorded a loss per share of 0.04. The entity last dividend was issued on the 18th of November 2025. The firm had 2:1 split on the 23rd of July 2007. Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. Innospec Inc. was founded in 1938 and is headquartered in Englewood, Colorado. Innospec operates under Specialty Chemicals classification in the United States and is traded on NASDAQ Exchange. It employs 1900 people. To learn more about Innospec call Patrick Williams at 303 792 5554 or check out https://innospec.com.

Innospec Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Innospec insiders, such as employees or executives, is commonly permitted as long as it does not rely on Innospec's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Innospec insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Pair Trading with Innospec

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Innospec position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innospec will appreciate offsetting losses from the drop in the long position's value.

Moving against Innospec Stock

  0.51AAPL Apple IncPairCorr
  0.5MAPSW WM TechnologyPairCorr
  0.34MSFT MicrosoftPairCorr
The ability to find closely correlated positions to Innospec could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Innospec when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Innospec - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Innospec to buy it.
The correlation of Innospec is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Innospec moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Innospec moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Innospec can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Innospec Stock Analysis

When running Innospec's price analysis, check to measure Innospec's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innospec is operating at the current time. Most of Innospec's value examination focuses on studying past and present price action to predict the probability of Innospec's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innospec's price. Additionally, you may evaluate how the addition of Innospec to your portfolios can decrease your overall portfolio volatility.